NYS ADAP Includes New Hep C meds on Formulary

New York State AIDS Drug Assistance Program Adds First HCV Direct-Acting Antiviral (DAA) to its Formulary

Following successful pricing negotiations with Merck, AbbVie and Bristol Myers Squibb by the National ADAP Crisis Task Force, in which New York has a leadership role, the New York State Department of Health, AIDS Drug Assistance Program (ADAP) will be offering  access to the following Hepatitis C agents for participants in the state’s AIDS Drug Assistance Program:

  • Zepatier (Merck)
  • Viekira Pak
  • Viekira XR (AbbVie)
  • Daklinza (Bristol Myers Squibb)

This formulary addition is effective November 28, 2016.

Last Updated on May 11, 2020 by HepFree NYC


©2021 HepFree.NYC. All rights reserved. Site by Lookit®


Log in with your credentials

Forgot your details?